We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » STUDY: LONG Rx CLINICAL TRIALS EQUATE TO GREATER FAILURE RATES
STUDY: LONG Rx CLINICAL TRIALS EQUATE TO GREATER FAILURE RATES
December 10, 2004
While nearly three-quarters of all investigative drugs fail to make it through clinical trials, the chances of a particular drug reaching the market decrease as the time to complete the trials increases, according to a new study that assesses the prospects of drugs in the pipeline.